132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$380.6B
P/E ttm
105.6
Fwd P/E
13.3
Beta
0.30
Day range
$215.40
52w range
$190.75 – $237.11
Avg vol
6.6M
RSI(2)
53.0
ROE
—
Net mgn
5.8%
FCF mgn
33.1%
Debt/Eq
—
Div yld
325.00%
Sector
Healthcare
Industry
Drug Manufacturers - General
Next earn
2026-07-30
Matrix setup grades
Long
—
score 22 · tech 22 / 80 · support 0 / 20
above KC1 lower, +0.61 ATR from EMA21 · bullish engulfing
- · Bullish engulfing — body fully covers prior red bar
Short
—
score 12 · tech 12 / 80 · support 0 / 20
below KC1 upper, +0.61 ATR from EMA21 · no notable pattern
- · Aligned with weak downtrend
Options · swing
See more →
CALL
$220
2026-07-17
$6.45
PUT
$220
2026-07-17
$11.22
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-29
- EPS (act / est)
- 2.65 / 2.67
- Surprise
- -0.8%
- Next report
- 2026-07-30
About
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere…